Cargando…

SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma: A Novel Member of the Expanding Family of SMARCB1-deficient Neoplasms

Poorly differentiated sinonasal carcinomas are a heterogenous group of aggressive neoplasms that encompasses squamous cell carcinoma including basaloid variant, lymphoepithelial carcinoma, sinonasal undifferentiated carcinoma, and neuroendocrine-type small cell carcinoma. We herein describe 3 cases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agaimy, Abbas, Koch, Michael, Lell, Michael, Semrau, Sabine, Dudek, Wojciech, Wachter, David L., Knöll, Antje, Iro, Heinrich, Haller, Florian, Hartmann, Arndt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Raven Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141899/ https://www.ncbi.nlm.nih.gov/pubmed/24832165 http://dx.doi.org/10.1097/PAS.0000000000000236

Ejemplares similares

SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity
por: Chung, Sei Y., et al.
Publicado: (2023)

SMARCB1/INI1-deficient tumors of adulthood
por: Parker, Nathaniel A., et al.
Publicado: (2020)

Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms
por: Haberecker, Martina, et al.
Publicado: (2022)

Oncogenic roles of SMARCB1/INI1 and its deficient tumors
por: Kohashi, Kenichi, et al.
Publicado: (2017)

SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes
por: Lee, Victor Ho-Fun, et al.
Publicado: (2022)

SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature
por: AlMadan, Nasser M., et al.
Publicado: (2023)

Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor
por: Wei, Christina H., et al.
Publicado: (2023)

SMARCB1-deficient sinonasal carcinoma: a case report and literature review
por: Yanagawa, Naoki, et al.
Publicado: (2021)

Orbital Apex Syndrome Secondary to SMARCB1-Deficient Invasive Sinonasal Carcinoma
por: Massey, Denzel, et al.
Publicado: (2022)

The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report
por: Yoshida, Kazushi, et al.
Publicado: (2018)

SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
por: Rousseau, Guillaume, et al.
Publicado: (2011)

SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature
por: Hua, Yinan, et al.
Publicado: (2020)

An Adrenal SMARCB1/INI1 Deficient Proximal Epithelioid Sarcoma in a Middle-Aged Female: A Case Report
por: Brodie, Zachary, et al.
Publicado: (2022)

Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor
por: Duan, Zejun, et al.
Publicado: (2022)

SMARCB1/INI1-Deficient Extrarenal Rhabdoid Tumor: A Case Report of a Rare and Aggressive Soft Tissue Sarcoma
por: Parker, Nathaniel A, et al.
Publicado: (2020)

Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma
por: Valeri, Marina, et al.
Publicado: (2022)

A Novel Successful Case of Nasal and Sinus Yolk Sac Tumor With SMARCB1 (INI-1) Deficiency: A Case Report
por: He, Tianyu, et al.
Publicado: (2022)

Malignant rhabdoid tumor of the kidney in an adult with loss of INI1 expression and mutation in the SMARCB1 gene
por: Han, Eunkyung, et al.
Publicado: (2021)

SMARCB1/INI1 loss in skull base conventional chordomas: a clinicopathological and molecular analysis
por: Righi, Alberto, et al.
Publicado: (2023)

Extended pancreato-duodenectomy coupled with adjuvant chemotherapy for SMARCB1/INI1 deficient pancreatic carcinoma: A case report and literature review
por: Mugaanyi, Joseph, et al.
Publicado: (2021)

Gene of the month: SMARCB1
por: Kalimuthu, Sangeetha N, et al.
Publicado: (2016)

Case Report: SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels
por: Li, Chun-Yu, et al.
Publicado: (2021)

Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?
por: Msaouel, Pavlos, et al.
Publicado: (2019)

Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
por: Ngo, Carine, et al.
Publicado: (2022)

SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
por: Cooper, Garrett W., et al.
Publicado: (2022)

INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication
por: Dixit, Updesh, et al.
Publicado: (2021)

A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1
por: Rekhi, Bharat, et al.
Publicado: (2021)

Fulminant presentation of a SMARCB1-deficient, anterior cranial fossa tumor in adult
por: Levitan, Idan, et al.
Publicado: (2020)

SMARCB1‐deficient basal cell carcinoma of the prostate controlled using radiation therapy
por: Makabe, Shunta, et al.
Publicado: (2023)

Inhibition of MYC by the SMARCB1 tumor suppressor
por: Weissmiller, April M., et al.
Publicado: (2019)

Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells
por: Florian, Andrea C, et al.
Publicado: (2022)

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22
por: Pancione, Massimo, et al.
Publicado: (2013)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
por: Kobayashi, Toshinori, et al.
Publicado: (2023)

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
por: Richer, Wilfrid, et al.
Publicado: (2017)

INI-1-Deficient Sinonasal Carcinoma: Case Report with Emphasis on Differential Diagnosis
por: Alsayed, Anwaar M., et al.
Publicado: (2022)

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
por: Holdhof, Dörthe, et al.
Publicado: (2020)

An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report
por: Yu, Lu, et al.
Publicado: (2016)

Human Pluripotent Stem Cell Fate Regulation by SMARCB1
por: Carmel-Gross, Ilana, et al.
Publicado: (2020)

SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report
por: Mitsui, Nobuyuki, et al.
Publicado: (2021)

SMARCB1 regulates the hypoxic stress response in sickle cell trait
por: Soeung, Melinda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ofpi8tlv1vstk572ciqeo2q2io